New Drug For Hearing Loss Enters Clinical Testing

... Sound Pharmaceuticals initiatesclinical testing of SPI-1005 for the prevention and treatment of noiseinduced hearing loss. Sound Pharmaceuticals has started a 32 patient Phase 1 study ofSPI-1005 in normal healthy volunteers. SPI-1005 is an oral capsule, andcontains as its active ingredient a selenium based small molecule mimic ofthe enzyme glutathione peroxidase. [click link for full article] ...